Skip to main content

Table 1 Results of system suitability

From: A new validated stability-indicating RP-HPLC method for simultaneous quantification of dolutegravir and lamivudine in bulk and pharmaceutical dosage form

Parameters for system suitability Result Acceptance criteria
LAM DOL
Retention time 2.169 6.367 For information
%RSD for area count of 6 standard replicate injections 0.7 0.8 NMT 2.0
Tailing factor 1.34 1.12 NMT 2.0
Theoretical plates 7643 55924 NLT 2000
Resolution N/A 22.51 NLT 2.0